naurif 1mg/ml

Injection
Pack Size :   5 Bottle x 1 Strip
Generics :   Granisetron
Best Price * TK  241.65
* Delivery will be done in Dhaka city only.

More Information About - naurif 1mg/ml

Description

Generic Name

Granisetron

Precaution

Subacute intestinal obstruction or ileus. Moderate to severe hepatic impairment. Congenital long QT syndrome or other risk factors for QT prolongation (e.g. electrolyte abnormalities and cumulative high-dose anthracycline therapy). Pregnancy, lactation. Lactation: excretion in milk unknown; use with caution

Indication

Nausea and vomiting, Chemotherapy-induced nausea and vomiting, Post-operative nausea and vomiting

Contra Indication

Hypersensitivity.

Dose

N/A

Side Effect

>10% Headache (10-21%) 1-10% Diarrhea (1-9%),Constipation (3-18%),Asthenia (5%),Somnolence (10%),Sedation (10%),Drowsiness (10%) Frequency Not Defined Anxiety,Fatigue,Malaise,Increased LFTs

Pregnancy Category

Name : B
Description
Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Mode of Action

Granisetron is a selective 5-HT3-receptor antagonist with little or no affinity for other serotonin receptors. It blocks serotonin in the chemoreceptor zone.

Interaction

Phenobarbital may induce metabolism of granisetron.

Pregnancy Category Note

Pregnancy Category: B Lactation: excretion in milk unknown; use with caution

Adult Dose

Chemotherapy Induced Nausea & Vomiting Oral 1 mg PO 1 hr before chemotherapy, then 1 mg 12 hr after 1st dose; OR 2 mg 1 hr before chemotherapy IV 0.01 mg/kg/dose infused over 5 min or direct injected over 30 sec, 30 min before chemotherapy Radiation-Induced Nausea & Vomiting 2 mg PO, 1 hr before radiation treatment Postoperative Nausea & Vomiting Prevention: 1 mg (undiluted) IV push over 30 seconds; administer before anesthetic induction or immediately before reversal of anesthesia Treatment: 1 mg (undiluted) IV push over 30 seconds Elderly: Chemotherapy Induced Nausea & Vomiting Oral: 2 mg 1 hr before chemotherapy, then 1 mg 12 hr after 1st dose; OR 2 mg 1 hr before chemo IV: 0.01 mg/kg/dose infused over 5 min or direct injected over 30 sec, 30 min before chemotherapy Radiation-Induced Nausea & Vomiting 2 mg PO, 1 hr before radiation treatment Postoperative Nausea & Vomiting Prevention: 1 mg (undiluted) IV push over 30 seconds; administer before anesthetic induction or immediately before reversal of anesthesia Treatment: 1 mg (undiluted) IV push over 30 seconds Hepatic impairment No dosage adjustment required

Child Dose

Chemotherapy Induced Nausea & Vomiting <2 years: Safey and efficacy not established 2-16 years: As adults; 0.01 mg/kg infused over 5 min or direct inj over 30 sec, 30 min before chemotherapy Oral administration: Currently FDA-approved for IV administration in children; safety and efficacy of oral administration is not established Postoperative Nausea & Vomiting Safety and efficacy not established Not approved for postoperative N/V in pediatric patients because of lack of efficacy and QT prolongation observed in clinical trials

Renal Dose

Renal impairment IV Severe (CrCl <30 mL/min): Total clearance was not affected in patients with severe renal failure who received a single 40 mcg/kg IV dose PO No dosage adjustment required

Administration

May be taken with or without food. Take up to 1 hr before chemotherapy.

Disclaimer

The information provided herein are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please note that this information should not be treated as a replacement for physical medical consultation or advice. Great effort has been placed to provide accurate and comprehensive data. However, Medicart along with its authors and editors make no representations or warranties and specifically disclaim all liability for any medical information provided on the site. The absence of any information and/or warning to any drug shall not be considered and assumed as an implied assurance of the Company.

Others Product

In Stock
Suspension Marlox Plus 200ml Susp Magaldrate + Simethicone Incepta Pharmaceuticals Ltd.
Tk 110
In Stock
Tablet UROPASS-D - 0.4 MG Tamsulosin Acme Laboratories Ltd.
Tk 80
In Stock
Prescribed
Oral Solution Defrol - 100ml Ascorbic Acid + Biotin + Cholecalciferol (Vit. D3) Acme Laboratories Ltd.
Tk 75
In Stock
Prescribed
Inhalation Aeronid HFA - 200mcg Budesonide Beximco Pharmaceuticals Ltd.
Tk 420